USA Penny Stock Top Stock Under $3 for 2022  ObsEva Stock

ObsEva produces therapeutics targeted at women’s reproductive health 2 Reasons to consider investing in OBSV stock 

First of all, ObsEva reported a net gain of $800,000 for the quarter that ended Sept. 30.  cash position of $62.9 million, up from $31.2 million at the end of 2020. 

Positive factor behind ObsEva: That is, it recently was added to the   Biotechnology Index 

Don't Miss  Penny Stocks

 ObsEva’s target price of $10.75 is well above its current price of $2.